DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pamrevlumab
Pamrevlumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
2017 Immuno-Oncology Medicines in Development
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Antibodies to Watch in 2021 Hélène Kaplona and Janice M
Overview of Planned Or Ongoing Studies of Drugs for the Treatment of COVID-19
United States Patent (10 ) Patent No.: US 10,471,211 B2 Rusch Et Al
Stembook 2018.Pdf
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
Airway Redox Homeostasis and Inflammation Gone Awry
Horizon Scanning Status Report December 2020
2018 Medicines in Development for Cancer
New Developments in Pulmonary Disease
(INN) for Biological and Biotechnological Substances
OCTOBER 2019 Mrx Pipeline a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
PDF of Antibody News
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
The State-Of-The-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
Top View
PDCO Agenda of the 20-23 April 2021 Meeting
International Nonproprietary Names for Pharmaceutical Substances (INN)
2020 Medicines in Development ꟷ Cancer
(12) Patent Application Publication (10) Pub. No.: US 2017/0173267 A1 Ashmead Et Al
Therapeutic Targets in the Pancreatic Adenocarcinoma Microenvironment: Past Challenges and Opportunities for the Future
A View Into Upcoming Specialty & Traditional Drugs
Horizon Scanning COVID-19 Supplement Status Report, Volume
Draft PDCO Agenda 18-21 May 2021
AD-214, an Fc-Fusion Market Cap Ful
PDF of Antibody News
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
2020 Medicines in Development for Children
Challenges for Drug Repurposing in the COVID-19 Pandemic Era
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
(INN) for Biological and Biotechnological Substances
WO 2018/231759 Al 20 December 2018 (20.12.2018) W !P O PCT
Biosimilar Monoclonalantibodies
Antibody-Based Immunotherapeutic Strategies for COVID-19
A Guide to Clinical Trials in Pancreatic Cancer Pancreatic Cancer
The Time to Offer Treatments for Covid-19
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives
W O 2020/219868 a L 29 October 2020 (29.10.2020)